Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla
  • India

    Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

    Shalini Ojha
    Written by
    Shalini Ojha
    Twitter
    Last updated on Nov 05, 2020, 02:24 pm
    Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla
  • Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

    SII has partnered with UK pharma giant AstraZeneca to mass produce the vaccine being developed by the prestigious University of Oxford.

    Here's more on what he said.

  • In this article
    Success of trials will dictate the future of vaccine No concerns related to Covishield so far: Poonawalla Results from trials gave hope to a ripped apart globe Poonawalla assured the vaccine will be affordable Does government have Rs. 80,000 crore ready, Poonawalla had asked We don't agree with Poonawalla's calculation: Centre Centre claimed it has required amount of money
  • Statement

    Success of trials will dictate the future of vaccine

    Success of trials will dictate the future of vaccine
  • Speaking to Mint, Poonawalla said the availability of the vaccine, obviously, depends on the results from trials.

    "Based on the success of the trials in India and the United Kingdom, and if approvals from regulatory bodies are in place in time, then we can expect the vaccine to be available in India by January 2021, only if it's proven immunogenic and efficacious," he added.

  • Quote

    No concerns related to Covishield so far: Poonawalla

  • "The current data pertaining to the trials show that there are no immediate concerns pertaining to Covishield (the vaccine). So far, thousands of people have had it in India and abroad with no safety concerns," Poonawalla stressed.

  • Vaccine

    Results from trials gave hope to a ripped apart globe

  • Oxford's product is being dubbed as the frontrunner in the vaccine race after it was known that its doses provided double protection against the disease by generating virus-attacking T-cells.

    The vaccine is being tested across 17 sites in India. In phase II, nearly 1,600 participants, aged between 18 to 55, were administered doses. The third stage trials have also started at some sites.

  • Cost

    Poonawalla assured the vaccine will be affordable

  • SII's deal with AstraZeneca positions India in a better place, as it means the country will get the vaccine sooner than others.

    However, there have been some concerns about the vaccine's cost.

    When asked about this, Poonawalla said, "We are in conversation with the government regarding the pricing. We are certain that it will be affordable for all."

  • Details

    Does government have Rs. 80,000 crore ready, Poonawalla had asked

    Does government have Rs. 80,000 crore ready, Poonawalla had asked
  • However, in September, Poonawalla had asked if the government has Rs. 80,000 crore ready within the next one year for vaccine distribution.

    "Will the government of India have 80,000 crores available, over the next one year? Because that's what @MoHFW_INDIA needs, to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle," he had tweeted.

  • Response

    We don't agree with Poonawalla's calculation: Centre

  • Subsequently, the government said it did not agree with Poonawalla's calculation.

    Asserting that the SII boss clarified his statement soon, Union Health Secretary Rajesh Bhushan said, "We do not agree with the calculation of Rs. 80,000 crore."

    He said Centre formed a National Expert Group on Vaccine Administration to look into all things vaccine related. The body also pondered about the money needed.

  • Quote

    Centre claimed it has required amount of money

  • "We have mulled over process of COVID-19 vaccine distribution and the amount required for it in terms of prioritization of population and the staggered immunization for this prioritization. In the meetings, we have calculated the amount required and currently, that amount is available," Bhushan claimed.

  • India
  • Oxford
  • United Kingdom
  • University of Oxford
  • MOHFW
  •  
Latest News
  • Chinese hackers target 12 Indian organizations; infiltrated power sector: Study
    Chinese hackers target 12 Indian organizations; infiltrated power sector: Study
    Science
  • Big B undergoes eye surgery, asks fans to excuse typos
    Big B undergoes eye surgery, asks fans to excuse typos
    Entertainment
  • Mercedes-Benz A-Class Limousine first impression: A feature-packed compact luxury sedan
    Mercedes-Benz A-Class Limousine first impression: A feature-packed compact luxury sedan
    Auto
  • OPPO F19 Pro, Pro+ teased in India; key specifications leaked
    OPPO F19 Pro, Pro+ teased in India; key specifications leaked
    Science
  • Unavailable slots, registration glitches: Co-WIN app faces issues
    Unavailable slots, registration glitches: Co-WIN app faces issues
    India
Related Timelines
  • Coronavirus: India's tally reaches 10.75 million with 11K+ new cases
    Coronavirus: India's tally reaches 10.75 million with 11K+ new cases
    India
  • Coronavirus: India's tally reaches 10.73 million with 13K new cases
    Coronavirus: India's tally reaches 10.73 million with 13K new cases
    India
  • Coronavirus: India's tally reaches 10.72 million with 12K new cases
    Coronavirus: India's tally reaches 10.72 million with 12K new cases
    India
  • Coronavirus: India's tally reaches 10.7 million with 11K+ new cases
    Coronavirus: India's tally reaches 10.7 million with 11K+ new cases
    India
Trending Topics
ISRO Vaccine
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Donald Trump YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga Honda
Batman Football News Golden Globe Award BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota
Fashion Tips Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar
Premier League Big Bang Theory X-Men TATA
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021